Smith Anglin Financial, LLC Amneal Pharmaceuticals, Inc. Transaction History
Smith Anglin Financial, LLC
- $1.04 Billion
- Q4 2024
A detailed history of Smith Anglin Financial, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Smith Anglin Financial, LLC holds 29,000 shares of AMRX stock, worth $258,100. This represents 0.02% of its overall portfolio holdings.
Number of Shares
29,000
Previous 29,000
-0.0%
Holding current value
$258,100
Previous $241,000
4.98%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding AMRX
# of Institutions
205Shares Held
124MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$132 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$110 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$100 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$95.4 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$79.9 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.35B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...